Literature DB >> 29188514

CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology.

Wen-Hsuan Wu1,2,3, Yi-Ting Tsai1,2,3, Sally Justus1,2,3, Galaxy Y Cho1,2,3, Jesse D Sengillo1,2,3,4, Yu Xu1,2,3,5, Thiago Cabral1,2,3,6,7, Chyuan-Sheng Lin8, Alexander G Bassuk9, Vinit B Mahajan10,11, Stephen H Tsang12,13,14,15,16.   

Abstract

CRISPR/Cas9 genome engineering is currently the leading genome surgery technology in most genetics laboratories. Combined with other complementary techniques, it serves as a powerful tool for uncovering genotype-phenotype correlations. Here, we describe a simplified protocol that was used in our publication, CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa, providing an overview of each section of the experimental process.

Entities:  

Keywords:  CRISPR; Electroretinogram; Fundoscopy; Genome engineering; Optical-coherence tomography; Retinitis pigmentosa; sgRNA construct design

Mesh:

Substances:

Year:  2018        PMID: 29188514      PMCID: PMC9119419          DOI: 10.1007/978-1-4939-7522-8_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.

Authors:  Lijuan Zhang; Jianhai Du; Sally Justus; Chun-Wei Hsu; Luis Bonet-Ponce; Wen-Hsuan Wu; Yi-Ting Tsai; Wei-Pu Wu; Yading Jia; Jimmy K Duong; Vinit B Mahajan; Chyuan-Sheng Lin; Shuang Wang; James B Hurley; Stephen H Tsang
Journal:  J Clin Invest       Date:  2016-11-14       Impact factor: 14.808

2.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

3.  CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.

Authors:  Wen-Hsuan Wu; Yi-Ting Tsai; Sally Justus; Ting-Ting Lee; Lijuan Zhang; Chyuan-Sheng Lin; Alexander G Bassuk; Vinit B Mahajan; Stephen H Tsang
Journal:  Mol Ther       Date:  2016-05-20       Impact factor: 11.454

4.  Generating genetically modified mice using CRISPR/Cas-mediated genome engineering.

Authors:  Hui Yang; Haoyi Wang; Rudolf Jaenisch
Journal:  Nat Protoc       Date:  2014-07-24       Impact factor: 13.491

5.  Localization of a retroviral element within the rd gene coding for the beta subunit of cGMP phosphodiesterase.

Authors:  C Bowes; T Li; W N Frankel; M Danciger; J M Coffin; M L Applebury; D B Farber
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Halting progressive neurodegeneration in advanced retinitis pigmentosa.

Authors:  Susanne F Koch; Yi-Ting Tsai; Jimmy K Duong; Wen-Hsuan Wu; Chun-Wei Hsu; Wei-Pu Wu; Luis Bonet-Ponce; Chyuan-Sheng Lin; Stephen H Tsang
Journal:  J Clin Invest       Date:  2015-08-24       Impact factor: 14.808

  6 in total
  3 in total

Review 1.  The genome editing revolution: review.

Authors:  Ahmad M Khalil
Journal:  J Genet Eng Biotechnol       Date:  2020-10-29

Review 2.  TALENs-an indispensable tool in the era of CRISPR: a mini review.

Authors:  Anuradha Bhardwaj; Vikrant Nain
Journal:  J Genet Eng Biotechnol       Date:  2021-08-21

Review 3.  CRISPR/Cas systems usher in a new era of disease treatment and diagnosis.

Authors:  Ruiting Li; Qin Wang; Kaiqin She; Fang Lu; Yang Yang
Journal:  Mol Biomed       Date:  2022-10-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.